Long-term persistence of cellular immunity to Oka vaccine virus induced by pernasal co-administration with Escherichia coli enterotoxin in mice

Vaccine

Volumn 19, Issue 23-24, 2001, Pages 3131-3136

  Kamiya, Naoki ^a   Asano, Yoshizo ^a   Yoshino, Junji ^a   Sasaki, Keiko ^a   Honma, Yasuko ^a   Kawase, Hidetsugu ^a   Yokochi, Takashi ^b   Shiraki, Kimiyasu ^c   Tsuji, Takao ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Escherichia coli; Humoral immunity; Oka vaccine virus

Indexed keywords

CHICKENPOX VACCINE; ESCHERICHIA COLI ENTEROTOXIN; INTERLEUKIN 2; INTERLEUKIN 4; THYMIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIUM MUTANT; CELLULAR IMMUNITY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FOOT PAD; HUMORAL IMMUNITY; LONG TERM POTENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SPLEEN CELL;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; BACTERIAL TOXINS; CHICKENPOX VACCINE; ENTEROTOXINS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FEMALE; HYPERSENSITIVITY, DELAYED; IMMUNITY, CELLULAR; INTERLEUKIN-2; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED ICR; MUTATION; TIME FACTORS;

EID: 0035971967     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00032-9     Document Type: Article

References (23)

1. Varicella-zoster virus infection and immunization in the healthy and the immunocompromised host
2. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention
3. Attenuation and laboratory markers of the Oka-strain varicella-zoster virus
4. Herpes zoster in early infancy
5. Increased incidence of herpes zoster in normal children infected with varicella zoster virus during infancy: Community-based follow-up study
6. Lymphocyte responses to varicella zoster virus in the elderly
7. Cell-mediated immunity to varicella-zoster virus
8. Immune response to varicella-zoster virus glycoproteins in guinea pigs infected with Oka varicella vaccine
9. Vaccination of immunocompetent elderly subjects with a live attenuated oka strain of varicella zoster virus: A randomized, controlled, dose-response trial
10. Live vaccine used to prevent the spread of varicella in children in hospital
11. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays
12. Safety and cellular and humoral immune responses of a booster dose of varicella vaccine 6 years after primary immunization
13. Varicella vaccine: The American experience
14. Humoral immunoresponse to varicella-zoster virus pernasally coadministered with Escherichia coli enterotoxin in mice
15. Relationship between a low toxicity of the mutant A subunit of enterotoxigenic Escherichia coli enterotoxin and its strong adjuvant action
16. Rapid killing of murine lymph node T blasts by intestinal intraepithelial lymphocytes in vitro
17. Animal models of varicella
18. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties
19. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins
20. Lymphocyte responses and cytokines
21. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity
22. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit